Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

BACKGROUND: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric junction. METHODS: Patients received neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Moehler, Markus, Gockel, Ines, Roessler, Hans-Peter, Arnold, Dirk, Trarbach, Tanja, Thomaidis, Thomas, Klautke, Gunther, Rödel, Claus, Brenner, Baruch, Lang, Hauke, Galle, Peter R, Schimanski, Carl C, Schmidberger, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579685/
https://www.ncbi.nlm.nih.gov/pubmed/23394629
http://dx.doi.org/10.1186/1471-2407-13-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579685/
https://www.ncbi.nlm.nih.gov/pubmed/23394629
http://dx.doi.org/10.1186/1471-2407-13-75

Ejemplares similares